Complications of excimer surgery

Published on 08/03/2015 by admin

Filed under Opthalmology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1932 times

CHAPTER 27 Complications of excimer surgery

Preoperative assessment

Preoperative assessment should evaluate both ocular and medical conditions that may influence the outcome of CRS. The patient should be given a detailed informed consent including expectations and potential complications.

To protect the integrity of the corneal epithelium and postoperative wound healing, dry eye syndrome or uncontrolled blepharitis should be preoperatively treated. In patients with background of herpes keratitis, LASIK should only be performed after 1 year of inactivity without treatment and in absence of stromal disease. Consider oral antiviral prophylaxis1. Moreover, LASIK is contraindicated in anterior basement membrane dystrophy (ABMD), but photorefractive–phototherapeutic keratectomy (PRK-PTK) is an excellent option in myopic patients presenting recurrent epithelial erosions.

In patients with glaucoma, the intraoperative increase in intraocular pressure during suction may cause additional damage to the optic nerve. Moreover, falsely low intraocular pressure (IOP) measurements are obtained by applanation tonometry in thinned corneas or in those rare situations where there is accumulation of fluid at the interface. Dilated fundus examination is mandatory. Peripheral retinal degenerations predisposing to retinal tears should be treated.

Scotopic and photopic pupil size should also be measured. Patients with larger pupils should be warned of the increased risk for postoperative night vision disturbances.

Additionally, presbyopic patients should be informed about the different available options and their limitations. Despite a presbyopic compensation approach being used, near-vision correction with spectacles might still be required in some cases.

In-depth evaluation of corneal topography is a ‘must’ prior to refractive surgery to identify patients with risk of postoperative corneal ectasia. Corneal topographic warning signs include curvature abnormalities, thin central pachymetry, and/or asymmetry in peripheral pachymetry. Ablational corneal refractive procedures are contraindicated in such cases, except in particular situations. Due to the increased risk of visual disturbances and decreased quality of vision, the cornea should not be flattened to less than 36 D or steepened to more than 48 D2.

Finally, connective tissue or autoimmune diseases and systemic immunosuppression are relative contraindications of LASIK. Absolute contraindications are uncontrolled diseases, uncontrolled ocular allergy, and pregnant or nursing women.

Postoperative complications

Flap distortions: microstriae, macrostriae, and flap dislocation

Macrostriae are broad, parallel lines that reflect flap wrinkling. Pooling of fluorescein is seen over the base of the folds. Macrostriae may cause decreased best-spectacle corrected visual acuity (BSCVA) and visual disturbances, and constitute an emergency.

Only if detected and treated within the first 24 h of occurrence, it is possible to solve them. Lift the flap, clean the epithelium the gutter, float the flap with balanced salt solution (BSS), and smooth it back into position. If undetected or left untreated for 1 or more days, the folds become fixed due to epithelial remodeling over the folds and stromal collagen fibers contraction. De-epithelialization and swelling of the flap with sterile distilled water is essential to release fixed folds. Place a bandage contact lens (BCL) to stabilize the flap and reduce the risk of epithelial ingrowth. Prescribe topical antibiotics and steroids. If macrostriae persist despite hydration, traction and suturing of the flap are required. However, suturing itself may create new striae or induce regular or irregular astigmatism. In severe cases, amputating the flap or PTK may be effective5.

Microstriae are fine wrinkles in Bowman’s layer. Compared with macrostriae, microstriae are smaller, have a more random pattern, and exhibit negative fluorescein staining. Treatment of visually significant microstriae is the same as the one applied for macrostriae.

Prevention maneuvers include: maintain neutral hydration of the flap, avoid excessive manipulation, and allow the flap to stick well in the proper position. The patient should be instructed not to squeeze the eyelids during speculum removal, and not to rub the eye postoperatively. In some patients, a BCL or globe protectors might be useful.

Flap dislocations occur after ocular trauma (e.g. eye rubbing), especially in poorly adherent flaps. Reposition the flap as soon as the dislocation is detected to avoid visual sequelae.

Epithelial ingrowth

Epithelial ingrowth is the most frequent complication of LASIK (1–10% of cases). It is an active proliferation of corneal and/or conjunctival epithelium at the flap edge that grows under the flap into the interface. Risk factors include flap striae, excessive manipulation of the flap and epithelial defects during surgery, poor flap adherence, defective microkeratomes or microkeratome-related flap complications, relifting the flap, and LASIK surgery over previous corneal surgery (e.g. radial keratotomy).

The benign form of presentation (grayish, small spots or lines at the peripheral edge of the flap) usually remains stable and is asymptomatic. On the other hand, a more diffuse form (cysts or sheaths of epithelium) may progress towards the center of the pupil and lead to irregular astigmatism (especially hyperopic astigmatism) and decreased visual acuity (Fig. 27.1).

Prevention is directed towards minimizing surgical trauma to the corneal flap, and dealing with flap-related complications such as flap folds or misalignment in a timely manner. The use of a BCL is advised in presence of epithelial defects or after repositioning the flap.

Close follow-up is advised to rule out progression. Surgical intervention is indicated when the epithelial ingrowth progresses towards the visual axis or causes irregular astigmatism, or in presence of flap melting. Once the flap is lifted with a thin spatula, clean the epithelium from the stroma, the undersurface of the flap, and the edges of the wound. Then, carefully reposition and suture the flap. Place a BCL until the epithelium closes the wound5.

In severe forms or recurrences, several additive techniques have been used to eliminate potential residual cells in the stroma, and reduce the incidence of recurrences. These include the application of ethanol 20%–50% with a microsponge after cleaning the epithelium, PTK in the undersurface of the flap and the stromal bed, cryotherapy, or mitomycin C. However, we prefer not to use of any of them. In most series, reLASIK with a manual dissection technique (relift) is associated with a higher incidence (2–20%). On the other hand, its incidence seems to be lower after FS laser assisted LASIK both in primary and secondary cases. This is why we have explored the concept of FS laser assisted enhancements after a primary mechanical case6.

Inflammation and/or infections

Diffuse lamellar keratitis, toxic syndrome, and GAPP syndrome

Diffuse lamellar keratitis (DLK) is a whitish, granular, culture negative, inflammatory response of the corneal lamellae that occurs in the early postoperative period in 0.67% of cases. Although still unclear, contaminants introduced in the lamellar interface during surgery, epithelial defects, and femtosecond laser may trigger the inflammatory cascade. Late-onset DLK has also been reported associated with epithelial defects, reactivation of herpetic keratitis, or viral keratoconjunctivitis10 DLK may cause scarring and visual loss11.

Prompt diagnosis and treatment are essential to avoid visual sequelae. The cellular reaction in the interface is usually apparent in the first 24 hours, and starts at the periphery of the lamellar flap5,11. It is important to differentiate DLK from punctate epithelial keratopathy (stains with fluorescein), or the presence of meibomian gland or tear film debris that become trapped under the flap (yellowish appearance).

Stages 1 (white granular cells in the periphery of the flap, with sparing of the visual axis) and 2 (involving the visual axis in ‘sands of the Sahara’ appearance) require hourly topical steroids (prednisone) and daily monitoring. Most cases resolve in 7–10 days (Fig. 27.2A). Steroid-induced glaucoma may occur. If a pocket of fluid develops in the lamellar interface due to the increased IOP, the measurement of IOP by central Goldmann applanation tonometry appears falsely low, and IOP should be confirmed in the periphery of the cornea11.

In 1/500 cases, the inflammation progresses despite treatment to Stage 3: denser aggregation of white cells in the visual axis with clearing in the periphery. Untreated Stage 3 DLK results in visual loss due to permanent scarring. Lift the flap and irrigate the interface with BSS with a blunt canula to debulk the inflammatory reaction. Avoid aggressive scraping of the flap or stromal bed with bladed instruments. Taper topical steroids as the cellular reaction resolves. Rarely, stromal melting, permanent scarring, and visual loss develop (Stage 4). Avoid lifting and irrigation at this point as it may result in additional tissue loss.

GAPP (Good acuity plus photophobia) syndrome or most commonly known as TLS (“transient light sensitivity”) is a reaction of unknown origin related to femtosecond laser that usually appears 2–6 weeks after uneventful LASIK. An inflammatory base is suspected as it resolves within 1 week of steroid treatment.

Sonmez and Maloney described a new syndrome of unknown cause associated with excimer laser ablations (PRK and LASIK), the ‘toxic syndrome’: a non-inflammatory central corneal opacification with a significant hyperopic shift. The opacification gradually clears over a period of 2–18 months, leaving the eye hyperopic (more than +2D). Enhancement is indicated to treat residual hyperopia and remove residual striae. Corticosteroid treatment is not indicated12.

Infections

Infections after excimer laser surgery are very rare (0.02–1.5%), but may lead to moderate to severe visual loss in up to 49.4% of the eyes affected. Early-onset infections (≤7 days of surgery) occur in 49.4% of cases, and are generally caused by Gram-positive bacteria (S. aureus), whereas late-onset infections (≥10 days after surgery) represent 50.6% of cases, and are mainly caused by atypical mycobacteria (Mycobacterium chelonae) (Fig. 27.2B). Fungal infections are less frequent (up to 20% of late-onset cases), but may cause extremely severe infections that may end up in endophthalmitis and severe visual loss. Sources of infection include patients’ eyelids, surgical instruments, and postoperative inoculation by the patient.

Infections after LASIK present with infiltrates and inflammation in the corneal interface (virtual space where any cell tends to accumulate). Differential diagnosis with DLK is sometimes arduous. Infections are suspected with the appearance of interface inflammation more than 1 week after LASIK, the presence of focal infiltrates, corneal flap and epithelium involvement, and the absence of response to topical corticosteroids. Melting of the lamellar flap may occur in up to 13.3% of cases.

Promptly start with topical, broad-spectrum antibiotics. No significant relationship between systemic antibiotic use and final visual outcome has been demonstrated. If no response or worsening is observed despite 7 days of treatment, consider the possibility of a fungal infection.

As antibiotic penetration to the interface is limited, lifting of the flap for antibiotic irrigation, scraping of the interface for culture, and repositioning of the flap are recommended. However, flaps may be therapeutically removed when they are considered to be the source of infection, or important melting is seen. Almost 60% of such cases had moderate or severe visual loss.

Therapeutic penetrating or lamellar keratoplasty is rarely required. The main indications are: persistent, worsening infiltrate despite 2–12 weeks of medical therapy, progressive, uncontrolled corneal thinning or perforation, and scarring and irregular astigmatism13.

Corneal ectasia

Post-LASIK ectasia has an estimated incidence of 0.04–0.6%, and leads to irregular astigmatism and decrease of BSCVA. Risk factors include high myopia, residual stromal bed (RSB) thickness less than 250 µm, low preoperative corneal thickness, and forme frustre keratoconus. Young age and steep cornea are the main risk factors for ectasia development in patients with normal topography2.

As previously mentioned, corneal ablational procedures are absolutely contraindicated in patients with ectatic disorders (keratoconus and pellucid marginal degeneration) and abnormal topographic patterns including elevated I-S values (specially if greater than 1.4 D), asymmetric inferior corneal steepening, skewed radial axes above and below the horizontal meridian, and asymmetry of topographic patterns between eyes. Randleman et al. have developed a scoring system to preoperatively establish the risk for postoperative ectasia2.

Avoiding surgery in high risk cases is the hallmark for ectasia prevention. Moreover, measuring RSB using intraoperative pachymetry or optical coherence tomography, specially in re-treatments, is essential to ascertain that further ablation is safe.

Visual rehabilitation is usually achieved with RGPCL. Intracorneal rings may regularize corneal topography, and improve BSCVA in some cases. Corneal collagen cross-linking (CCL), combined with intracorneal rings or not, may stop the progression of the corneal ectasia. Corneal transplantation is required when the other options fail to restore functional visual acuity.

References

1 de Rojas Silva V, Rodríguez-Conde R, Cobo-Soriano R, et al. Laser in situ keratomileusis in patients with a history of ocular herpes. J Cataract Refract Surg. 2007;33:1855-1859.

2 Randleman JB, Woodward M, Lynn MJ, et al. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology. 2008;115:37-50.

3 Lee JK, Nkyekyer EW, Chuck RS. Microkeratome complications. Curr Opin Ophthalmol. 2009;20:260-263.

4 Albelda-Valles JC, Marti-Reyes C, Ramos F, et al. Effect of preoperative keratometric power on intraoperative complications in LASIK in 34099 eyes. J Refract Surg. 2007;23:592-597.

5 Schallhorn SC, Amesbury EC, Tanzer DJ. Avoidance, recognition, and management of LASIK complications. Am J Ophthalmol. 2006;141:733-739.

6 Güell JL, Elies D, Gris O, et al. Femtosecond laser assisted enhancements after LASIK. Journal Cataract Refract Surgery. April 2011. In press

7 Reinstein DZ, Archer TJ, Gobbe M. Combined corneal topography and corneal wavefront data in the treatment of corneal irregularity and refractive error in LASIK or PRK using the Carl Zeiss Meditec MEL 80 and CRS-Master. J Refract Surg. 2009;25:503-515.

8 Güell JL, Pujol J, Arjona M, et al. OQAS: A new technique instrument for an objective clinical evaluation of the ocular optical quality. Correspondence. J Cataract Refract Surgry July. 2004;(30):1598-1600.

9 Vilaseca M, Padilla A, Ondategui J, et al. Effect of laser in situ keratomileusis on vision analyzed using preoperative Optical Quality. J Cataract Refrac Surg. 2010;36:1945-1953.

10 Gris O, Güell JL, Wolley-Dod C, et al. Diffuse lamellar keratitis and corneal edema associated with viral keratoconjunctivitis 2 years after laser in situ keratomileusis. J Cataract Refract Surg. 2004;30:1366-1370.

11 Knorz MC. Flap and interface complications in LASIK. Curr Opin Ophthalmol. 2002;13:242-245.

12 Sonmez B, Maloney RK. Central toxic keratopathy: description of a syndrome in laser refractive surgery. Am J Ophthalmol. 2007;143:420-427.

13 Chang MA, Jain S, Azar DT. Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol. 2004;49:269-280.